RecallCheckr

Critical recall: Death or serious injury has been reported or is considered likely. Stop using this product now.

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) 2023-06-28 Health critical FDA
Health · FDA · Recall #FDA-Z-1722-2023

ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G; Implantable Cardioverter… Recall

Issued June 28, 2023 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

In June 2023, Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) recalled the ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G; Implantable Cardioverter…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.

Compiled by Maya Ellison, RecallCheckr

What this means for you

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

What you should do

  1. 1 Stop using ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model Number DDPA2D1G; Implantable Cardioverter… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Category
Health
Recall date
June 28, 2023
Units affected
Not reported
Sold at
US Nationwide - Worldwide Distribution
Recall number
FDA-Z-1722-2023
Made in
United States
Issuing agency
FDA

In context

Read the official FDA notice

Related recalls